| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6086be35a3fb922a66dd2d91524920ad |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-523
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-6068
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2750-10022
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2750-10034
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-035 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-005
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-12 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-21
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-63
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-112 |
| filingDate |
2010-09-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2011-04-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4c86ff74e96342804fce437d3227be71
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6eb4aaf1b2cab612ff42a4713b602766
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0178a0ec2e59198a762757c386d8a9a6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_58cb5fcea61581a97f6a20bb424cbb3f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d9e533a0322402cfb4d29daf923f9f2b |
| publicationDate |
2011-04-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-101030792-B1 |
| titleOfInvention |
Vector for surface expression of porcine circovirus 2 (PCB2) gene and transformed Salmonella vaccine strain |
| abstract |
The present invention relates to a recombinant vector for cell surface expression of a pig circovirus (PCV) gene using a non-pathogenic strain Salmonella-derived extracellular membrane protein and / or a Salmonella vaccine strain transformed therewith, in the prevention and treatment of diseases caused by PCV2 infection. It relates to the use of. The present invention is useful for the production and utilization of multivalent vaccines having excellent effects on preventing diseases caused by Salmonella as well as PCV2 virus by using live vectors expressing structural proteins of PCV2 virus using such non-pathogenic strain Salmonella. Do. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20140111541-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20160048014-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2014142515-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101438542-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-102217387-B1 |
| priorityDate |
2010-09-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |